Strober, B.; Gottlieb, A.; Tha?i, D.; Puig, L.; Colombo, M. J.; Kundu, S.; Kisa, R.; Banerjee, S. An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Reduced Absolute Psoriasis Area and Severity Index in a Phase 2 Trial in Psoriasis. J of Skin 2020, 4, s27.